GSK-204980

Study Sponsor: GSK

Study Title

204980: An open-label study to evaluate the correct use of placebo ELLIPTA™ dry powder inhaler (DPI) compared to placebo metered dose inhalers (MDI) in subjects with moderate persistent asthma

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

204980

Trial Registry Identification Number(#'s)

NCT02794480

Medical Condition

Asthma

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204980

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02794480

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2019